Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Reprod ; 101(4): 832-841, 2019 10 25.
Article in English | MEDLINE | ID: mdl-31276578

ABSTRACT

CONTEXT: Prokineticin 1 (PROK1) quantification in global follicular fluid (FF) has been recently reported as a predictive biomarker of in vitro fertilization (IVF) outcome. It is now necessary to evaluate its clinical usefulness in individual follicles. OBJECTIVES: To evaluate the clinical value of PROK1 secretion in individual FF to predict oocyte competence. To determine the impact of follicular size, oocyte maturity, and gonadotropin treatments on PROK1 secretion. DESIGN AND SETTING: Prospective cohort study from May 2015 to May 2017 at the University Hospital of Grenoble. PATIENTS: A total of 69 infertile couples underwent IVF. INTERVENTION(S): Collection of 298 individual FF from 44 women undergoing IVF; 52 individual cumulus cell (CC) samples and 15 CC primary cultures from 25 women undergoing IVF-intracytoplasmic sperm injection (ICSI). MAIN OUTCOME MEASURE(S): Oocyte competence was defined as the ability to sustain embryo development to the blastocyst stage. Follicular size was measured by 2D-sonography. PROK1 concentration was quantified by ELISA assay. RESULTS: PROK1 concentration was correlated to follicular size (r = 0.85, P = 2.2 × 10-16). Normalized PROK1 concentration in FF was predictive of subsequent oocyte competence (AUROC curve = 0.76 [95% CI, 0.69-0.83]; P = 1.7 × 10-9), irrespectively of day-2 embryo morphokinetic parameters. The expression and secretion of PROK1 were increased in FF and CC of mature oocytes (P < 0.01). Follicle Stimulating Hormone and hCG up-regulated PROK1 secretion in CC primary cultures (P < 0.01; P < 0.05), probably through the cAMP pathway (P < 0.01). CONCLUSIONS: PROK1 quantification in individual FF could constitute a new predictive biomarker of oocyte competence in addition with embryo morphokinetic parameters. TRIAL REGISTRATION NUMBER: none.


Subject(s)
Biomarkers/analysis , Embryonic Development , Follicular Fluid/chemistry , Gastrointestinal Hormones/analysis , Oocytes/physiology , Vascular Endothelial Growth Factor, Endocrine-Gland-Derived/analysis , Biomarkers/metabolism , Cells, Cultured , Cohort Studies , Embryonic Development/drug effects , Embryonic Development/genetics , Embryonic Development/physiology , Female , Fertilization in Vitro , Follicular Fluid/metabolism , France , Gastrointestinal Hormones/genetics , Gastrointestinal Hormones/metabolism , Gene Expression/drug effects , Hormones/pharmacology , Humans , Oocyte Retrieval/standards , Oocytes/cytology , Oogenesis/drug effects , Oogenesis/genetics , Oogenesis/physiology , Pregnancy , Pregnancy Rate , Prognosis , Prospective Studies , Quality Control , Sperm Injections, Intracytoplasmic , Treatment Outcome , Vascular Endothelial Growth Factor, Endocrine-Gland-Derived/genetics , Vascular Endothelial Growth Factor, Endocrine-Gland-Derived/metabolism
2.
Basic Clin Androl ; 28: 5, 2018.
Article in English | MEDLINE | ID: mdl-29760927

ABSTRACT

BACKGROUND: Robertsonian translocations (RobT) are common structural chromosome rearrangements where carriers display a majority of chromosomally balanced spermatozoa from alternate segregation mode. According to some monotony observed in the rates of balanced segregation, is sperm FISH analysis obsolete for RobT carriers? METHODS: Retrospective cohort research study on 23 patients analyzed in our center from 2003 to 2017 and compared to the data of 187 patients in literature from 1983 to 2017.Robertsonian translocation carriers were divided in six groups according to the chromosomes involved in the translocation: 9 patients from our center and 107 from literature carrying 45,XY,der(13;14) karyotype, 3 and 35 patients respectively with 45,XY,der(14;21), 5 and 11 patients respectively with 45,XY,der(13;15), 4 and 7 patients respectively with 45,XY,der(14;15), 1 and 4 patients respectively with 45,XY,der(13;22),and 1 and 10 patients respectively with 45,XY,der(14;22). RESULTS: Alternate segregation mode is predominant in our group of Robertsonian translocation carriers with 73.45% ±8.05 of balanced spermatozoa (min 50.92%; max 89.99%). These results are compliant with the data from literature for all translocations types (p > 0.05) and are consistent among the different types of Robertsonian translocations (p > 0.05) except for der(13;15) that exhibit lower balanced spermatozoa rates (p < 0.05 versus der(13;14), der(14;21), (13;21) and der(15;22)). Normozoospermic patients also display a significantly (p < 0.01) higher rate of balanced sperm cells than patients with abnormal seminograms whatever the defect implied. CONCLUSIONS: According to the discrepancies observed between der(13;15) and all the other Rob T carriers, the differences observed among patients presenting normal and abnormal sperm parameters and the input in genetical counselling, sperm FISH does not seem obsolete for these patients. Moreover, it seems important to collect more data for rare RobT.


CONTEXTE: Le mode de ségrégation chromosomique le plus fréquemment observé chez les patients porteurs de translocation robertsonienne est. un mode équilibré. Les données semblent varier peu selon la translocation analysée. La relative constance des résultats dans le cas de ces translocations robertsoniennes rend elle inutile ces analyses chromosomiques pour ces patients? PATIENTS ET MÉTHODES: Nous avons analysé de façon rétrospective les données spermatiques et de ségrégation méiotique de 23 patients porteurs de translocation robertsonienne, de 2003 à 2017 et comparé les résultats observés à ceux décrits dans la littérature pour 187 patients. RÉSULTATS: Le mode de ségrégation alterne est. prépondérant dans notre série de patients avec 73.45% ±8.05 de spermatozoïdes équilibrés (min 50.92%; max 89.99%). Ces résultats sont en accord avec les données de la littérature, toutes translocations confondues et selon le type de translocation (p > 0.05) sauf pour la translocation der(13;15) où ces taux sont significativement plus faibles (p < 0.05 vs der(13;14), der(14;21), (13;21) et der(15;22)). Nous observons également des taux de spermatozoïdes équilibrés significativement plus élevés chez les patients à spermogramme normal (p < 0.01). CONCLUSIONS: Les différences observées dans les taux d'aneuploïdies entre les translocations der(13;15) et les autres translocations robertsoniennes et entre les porteurs de translocation à spermogramme normal ou altéré, et l'utilité de ces données dans le conseil génétique conduisent à poursuivre l'analyse systématique de la ségrégation méiotique pour les patients porteurs de translocations robertsoniennes et ceci particulièrement pour les translocations rares.

3.
ANZ J Surg ; 88(7-8): E568-E572, 2018.
Article in English | MEDLINE | ID: mdl-29219230

ABSTRACT

BACKGROUND: Colorectal cancers represent a heterogenous group of tumours. While left segmental colectomy is an accepted and oncologically safe practice for left-sided colonic cancer (CC), some authors suggest that limited segmental resection of right-sided cancer should be debated in order to preserve length of the resected colon. To our knowledge, caecum and ascending CC have not been analysed as different groups of tumours. The objective of this study was to assess if, retrospectively, surgical treatment of caecal cancer differed from ascending CC. METHODS: A review of all consecutive patients with right colonic resection for cancer admitted to the University hospital of Grenoble from January 2005 to August 2016 was performed. Length of resected colon was compared between caecal primary and ascending CC. Other technical and pathological aspects were analysed such as minimal invasive surgery and number of harvested lymph nodes from anatomic specimens. RESULTS: Among operated patients, tumour was localized pre-operatively on caecum in 110 cases and on the right ascending colon in 119 cases. Pre-operative localization had no effect on resected colon length (mean 24.5 cm, 24 ± 10.34 versus 25 cm ± 7.28, P = 0.95), on the number of harvested lymph nodes with a mean of 15 (±7.6) nodes in the caecal group versus 15.2 (±7.3) (P = 0.72). We noticed 15 cases of discordance between pre- and post-operative localization (4 versus 11, P = 0.08). CONCLUSION: Length of resected colon does not differ depending on localization of tumour in our center.


Subject(s)
Colectomy/methods , Colon/anatomy & histology , Colonic Neoplasms/surgery , Aged , Cecal Neoplasms/pathology , Cecal Neoplasms/surgery , Colectomy/trends , Colon/pathology , Colon/surgery , Colonic Neoplasms/mortality , Colonic Neoplasms/pathology , Colorectal Neoplasms/mortality , Colorectal Neoplasms/pathology , Colorectal Neoplasms/surgery , Female , France/epidemiology , Humans , Lymph Nodes/pathology , Male , Mesentery/pathology , Mesentery/surgery , Minimally Invasive Surgical Procedures/methods , Neoplasm Staging , Perioperative Period/mortality , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...